Tirzepatide TFA (2023788-19-2 free base)( LY3298176 TFA )

Catalog No. M29808 CAS No. ——

Tirzepatide TFA (LY3298176 TFA) is a disaccharide dependent insulin peptide (GIP) and glucagon-like peptide-1 (glp-1) receptor agonist.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
100MG	Get Quote	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Tirzepatide TFA (2023788-19-2 free base)
Note

Research use only, not for human use.
Brief Description

Tirzepatide TFA (LY3298176 TFA) is a disaccharide dependent insulin peptide (GIP) and glucagon-like peptide-1 (glp-1) receptor agonist.
Description

Tirzepatide TFA (LY3298176 TFA) is a disaccharide dependent insulin peptide (GIP) and glucagon-like peptide-1 (glp-1) receptor agonist.
In Vitro

——
In Vivo

——
Synonyms

LY3298176 TFA
Pathway

Others
Target

Other Targets
Recptor

Glucose-dependent insulinotropic polypeptide (GIP), GLP-1 receptor
Research Area

——
Indication

——

Chemical Information

CAS Number

——
Formula Weight

4927.47
Molecular Formula

C227H349F3N48O70
Purity

>98% (HPLC)
Solubility

——
SMILES

——
Chemical Name

Sequence:Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-{diacid-gamma-Glu-(AEEA)2-Lys}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Frias JP, et al. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial. Lancet. 2018 Nov 17;392(10160):2180-2193.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

Product			Quantity Required*
Name *			E-mail Address *
Organization *			Phone Number
Remarks